SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Prysmian S.p.A. (PRYMY) trades at a trailing P/E of 34.7, forward P/E of 30.9. Trailing earnings yield is 2.88%, forward earnings yield 3.23%. PEG 0.54 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (40/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 30.9 (down from trailing 34.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.54 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 2.88% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.23% as earnings recover.
Overall SharesGrow Score: 64/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
40/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PRYMY
Valuation Multiples
P/E (TTM)34.7
Forward P/E30.9
PEG Ratio0.54
Forward PEG2.51
P/B Ratio0.00
P/S Ratio2.25
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.07
Forward EPS (Est.)$2.32
Book Value / Share$0.00
Revenue / Share$31.95
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2.88%
Forward Earnings Yield3.23%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.53 |
$7.57B |
$246M |
3.3% |
| 2017 |
$0.56 |
$7.9B |
$227M |
2.9% |
| 2018 |
$0.27 |
$10.16B |
$130M |
1.3% |
| 2019 |
$0.56 |
$11.52B |
$292M |
2.5% |
| 2020 |
$0.34 |
$10.02B |
$178M |
1.8% |
| 2021 |
$0.59 |
$12.74B |
$308M |
2.4% |
| 2022 |
$0.95 |
$16.07B |
$504M |
3.1% |
| 2023 |
$0.91 |
$15.35B |
$529M |
3.4% |
| 2024 |
$1.26 |
$17.03B |
$729M |
4.3% |
| 2025 |
$2.07 |
$18.87B |
$1.22B |
6.5% |
